1. Academic Validation
  2. Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function

Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function

  • J Med Chem. 2022 Nov 24;65(22):15391-15415. doi: 10.1021/acs.jmedchem.2c01350.
Aiste Dobrovolskaite 1 Holly Moots 1 Mukund P Tantak 1 Kunal Shah 1 Jenna Thomas 1 Sharifa Dinara 1 Chelsea Massaro 1 Paul M Hershberger 2 Patrick R Maloney 2 Satyamaheshwar Peddibhotla 2 Eliot Sugarman 2 Sally Litherland 3 Juan Pablo Arnoletti 3 Rajiv Kumar Jha 4 David Levens 4 Otto Phanstiel 4th 1
Affiliations

Affiliations

  • 1 University of Central Florida, Biomolecular Research Annex, 12722 Research Parkway, Orlando, Florida 32826, United States.
  • 2 Sanford Burnham Medical Research Institute, 6400 Sanger Road, Orlando, Florida 32827, United States.
  • 3 Advent Health Cancer Institute, 2520 North Orange Ave, Suite 104, Orlando, Florida 32804, United States.
  • 4 Laboratory of Pathology, Center for Cancer Research, 10 Center Drive, Building 10, Room 2N106, Bethesda, Maryland 20892-1500, United States.
Abstract

Polyamine biosynthesis is regulated by ornithine decarboxylase (ODC), which is transcriptionally activated by c-Myc. A large library was screened to find molecules that potentiate the ODC inhibitor, difluoromethylornithine (DFMO). Anthranilic acid derivatives were identified as DFMO adjunct agents. Further studies identified the far upstream binding protein 1 (FUBP1) as the target of lead compound 9. FUBP1 is a single-stranded DNA/RNA binding protein and a master controller of specific genes including c-Myc and p21. We showed that 9 does not inhibit 3H-spermidine uptake yet works synergistically with DFMO to limit cell growth in the presence of exogenous spermidine. Compound 9 was also shown to inhibit the KH4 FUBP1-FUSE interaction in a gel shift assay, bind to FUBP1 in a ChIP assay, reduce both c-Myc mRNA and protein expression, increase p21 mRNA and protein expression, and deplete intracellular polyamines. This promising hit opens the door to new FUBP1 inhibitors with increased potency.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-151884
    FUBP1 Inhibitor